Allina Health Cancer institute

Minneapolis, Minnesota 55407-3799

2 studies enrolling now · 12 studies all time

What they study most

Acute Myeloid Leukemias, Adenoma, Bladder Cancer, Brain Cancer, Breast Cancer, Breast Neoplasms, Carcinoma, Non-Small- Cell Lung, Cervical Cancer, Colon Cancer, Colon Diseases, Colon Lesion, Colon Neoplasm

Studies at this site

• A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head) — Recruiting now
• cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease — Recruiting now
• A Study of SNDX-5613 in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias — Running, not enrolling
• A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer — Running, not enrolling
• A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer — Completed
• Prevention of Colorectal Cancer Through Multiomics Blood Testing — Completed
• Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer — Completed
• Study of Magrolimab Combination Therapy in Patients With Non-Surgically Removable Locally Advanced or Metastatic Triple-Negative Breast Cancer — Stopped early
• STRATA: Safe Testing of Risk for AsymptomaTic MicrohematuriA — Completed
• A Study of SEA-CD40 Given With Other Drugs in Cancers — Completed
• The Sanderson Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening — Completed
• A Safety Study of SGN-LIV1A in Breast Cancer Patients — Completed